Omid A. Hamid, MD

Omid Hamid, MD, is a professor of medicine at Cedars-Sinai. He is also director of clinical Research and Immunotherapy and director of Cutaneous Oncology and Melanoma at the The Angeles Clinic and Research Institute, both in Los Angeles, California.

Articles by Omid A. Hamid, MD

Dr Hamid on the Investigation of Fianlimab With Cemiplimab in Advanced Melanoma

ByOmid A. Hamid, MD

June 13th 2023

Omid Hamid, MD, discusses the investigation of the LAG-3 inhibitor fianlimab in combination with cemiplimab in patients with advanced melanoma who were naïve to anti–PD-1 agents in the advanced setting.

Dr. Hamid on TMB as a Biomarker for Immunotherapy Response in Melanoma

ByOmid A. Hamid, MD

August 24th 2020

Omid Hamid, MD, discusses the utility of tumor mutational burden as a biomarker for response to immunotherapy in patients with melanoma.

Dr. Hamid on Melanoma as a Therapeutic Driver for Other Cancers

ByOmid A. Hamid, MD

February 11th 2017

Omid A. Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses melanoma as a therapeutic driver for other tumor types during the 13th Annual 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® in Sunny Isles Beach, Florida.

Dr. Hamid on Patient Selection for Immunotherapy Regimens in Melanoma

ByOmid A. Hamid, MD

December 30th 2016

Omid A. Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses how to accurately select patients who are likely to have durable and long responses with single-agent immunotherapy versus combination treatment.